Corcept Therapeutics
CORT
#3673
Rank
โ‚น347.04 B
Marketcap
โ‚น3,294
Share price
-0.71%
Change (1 day)
-38.23%
Change (1 year)

Market capitalization of Corcept Therapeutics (CORT)

Market cap: โ‚น347.04 Billion

As of February 2026 Corcept Therapeutics has a market cap of โ‚น347.04 Billion. This makes Corcept Therapeutics the world's 3673th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Corcept Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น347.04 B-55.61%
2025โ‚น781.79 B65.77%
2024โ‚น471.61 B69.21%
2023โ‚น278.72 B54.06%
2022โ‚น180.92 B6.33%
2021โ‚น170.14 B-23.45%
2020โ‚น222.26 B124.87%
2019โ‚น98.84 B-8.02%
2018โ‚น107.45 B-18.35%
2017โ‚น131.60 B140.25%
2016โ‚น54.77 B50.96%
2015โ‚น36.28 B88.22%
2014โ‚น19.27 B-2.64%
2013โ‚น19.80 B153.37%
2012โ‚น7.81 B-48.72%
2011โ‚น15.23 B21.68%
2010โ‚น12.52 B55.4%
2009โ‚น8.05 B230.32%
2008โ‚น2.43 B-49.13%
2007โ‚น4.79 B242.12%
2006โ‚น1.40 B-62.31%
2005โ‚น3.71 B-39.32%
2004โ‚น6.12 B

End of Day market cap according to different sources

On Feb 25th, 2026 the market cap of Corcept Therapeutics was reported to be:

โ‚น346.44 Billion
by Nasdaq info icon info icon
โ‚น347.04 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น53.725 T 15,380.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น29.328 T 8,350.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น14.005 T 3,935.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น88.254 T 25,330.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น27.814 T 7,914.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น11.351 T 3,170.90%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚น97.72 B-71.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น72.38 B-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.073 T 209.27%๐Ÿ‡บ๐Ÿ‡ธ USA